In January, Elizabeth Holmes became the rare Silicon Valley founder convicted of fraud stemming from her time as CEO of her failed blood-testing startup, Theranos. On Thursday, her ex-boyfriend and former second-in-command, Ramesh "Sunny" Balwani, was also found guilty of fraud by a separate jury.

Their back-to-back trials spanned nearly a year and mark the final chapter of a startup that rose to prominence, and a $9 billion valuation, with a promise to revolutionize blood testing only to become a cautionary tale for tech founders and companies.

Now, the anticipation turns to their sentencing hearings, which are slated to take place weeks apart from one another. Holmes' sentencing has been pushed back to mid-October, after having previously been slated for September, and Balwani's is set for mid-November.

In January, Elizabeth Holmes became the rare Silicon Valley founder convicted of fraud stemming from her time as CEO of her failed blood-testing startup, Theranos. On Thursday, her ex-boyfriend and former second-in-command, Ramesh "Sunny" Balwani, was also found guilty of fraud by a separate jury.

Their back-to-back trials spanned nearly a year and mark the final chapter of a startup that rose to prominence, and a $9 billion valuation, with a promise to revolutionize blood testing only to become a cautionary tale for tech founders and companies.

Now, the anticipation turns to their sentencing hearings, which are slated to take place weeks apart from one another. Holmes' sentencing has been pushed back to mid-October, after having previously been slated for September, and Balwani's is set for mid-November.